• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Strategy of the medical treatment of angina pectoris].

作者信息

Nicolas G, Bouhour J B, Godin J F

出版信息

Arch Mal Coeur Vaiss. 1983 Feb;76 Spec No:111-5.

PMID:6134503
Abstract

The first objective is to correct any existing coronary risk factors but this must be achieved with discrimination. Smoking should be strictly forbidden, hypertension reduced and a more active life style encouraged. However, a more nuanced approach should be adopted towards dietetic problems, obesity and disorders of lipid metabolism. It is also very important to teach the patient to use glyceryl trinitrate correctly in the double objective of relieving pain as quickly as possible and of preventing pain by using it in certain critical situations. Clinical practice shows that patients often use glyceryl trinitrate too sparingly. When these general measures have been settled, treatment must be adapted to each particular situation. The patient's age, the frequency of attacks, trigger factors, the repercussions of the disease on the patient's life all have to be considered before deciding on the individual's treatment. In younger patients, a controlled exercise ECG is essential for selecting patients for surgery. The drugs of choice for stable angina are the betablockers which have been shown to be effective and well tolerated. When this group of drugs cannot be used or is ineffective, other major anti-anginal drugs may be chosen according to the individual terrain and their known secondary effects.

摘要

相似文献

1
[Strategy of the medical treatment of angina pectoris].
Arch Mal Coeur Vaiss. 1983 Feb;76 Spec No:111-5.
2
[Drug therapy of angina pectoris].[心绞痛的药物治疗]
Schweiz Med Wochenschr. 1983 Dec 17;113(50):1898-903.
3
Stable angina as a manifestation of ischemic heart disease: medical management.
Circulation. 1985 Dec;72(6 Pt 2):V145-54.
4
[The limits of the medical treatment of angina pectoris].[心绞痛的医学治疗限度]
Arch Mal Coeur Vaiss. 1983 Feb;76 Spec No:117-22.
5
What is optimal drug therapy in angina pectoris?
Cardiovasc Clin. 1983;13(1):209-20.
6
[Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].[评估氨氯地平和硝苯地平缓释片对稳定型劳力性心绞痛合并高血压患者疗效及不良反应的对比研究]
Przegl Lek. 1997;54(5):324-8.
7
[The choice of drugs and dosage for angina pectoris].
Schweiz Med Wochenschr Suppl. 1984;16:65-9.
8
Contemporary management of angina: part II. Medical management of chronic stable angina.当代心绞痛的管理:第二部分。慢性稳定型心绞痛的药物治疗
Am Fam Physician. 2000 Jan 1;61(1):129-38.
9
Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.稳定性心绞痛伴高血压的治疗:新型美托洛尔制剂(控释片)与硝苯地平之间的良好相互作用
Cardiologia. 1996 Jul;41(7):635-43.
10
[Selection of an anti-anginous drug for the treatment of angina pectoris (author's transl)].
Ann Cardiol Angeiol (Paris). 1976 Mar-Apr;25(2):141-8.